| 000 | 01286 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250515121058.0 | ||
| 264 | 0 | _c20080709 | |
| 008 | 200807s 0 0 eng d | ||
| 022 | _a1540-658X | ||
| 024 | 7 |
_a10.1089/adt.2007.121 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLi, Zhiyuan | |
| 245 | 0 | 0 |
_aPotential therapeutic targets for ATP-gated P2X receptor ion channels. _h[electronic resource] |
| 260 |
_bAssay and drug development technologies _cApr 2008 |
||
| 300 |
_a277-84 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAdenosine Triphosphate _xphysiology |
| 650 | 0 | 4 | _aBinding Sites |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIon Channel Gating _xdrug effects |
| 650 | 0 | 4 | _aLigands |
| 650 | 0 | 4 |
_aPain _xdrug therapy |
| 650 | 0 | 4 | _aPurinergic P2 Receptor Agonists |
| 650 | 0 | 4 | _aPurinergic P2 Receptor Antagonists |
| 650 | 0 | 4 |
_aReceptors, Purinergic P2 _xdrug effects |
| 650 | 0 | 4 | _aReceptors, Purinergic P2X |
| 650 | 0 | 4 |
_aThrombosis _xdrug therapy |
| 650 | 0 | 4 |
_aUrologic Diseases _xdrug therapy |
| 700 | 1 | _aLiang, Dong | |
| 700 | 1 | _aChen, Ling | |
| 773 | 0 |
_tAssay and drug development technologies _gvol. 6 _gno. 2 _gp. 277-84 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1089/adt.2007.121 _zAvailable from publisher's website |
| 999 |
_c17966206 _d17966206 |
||